Certified by Founder Lodge
Arsenal Biosciences, Inc.
United States - South San Francisco , CA
START UP
1 Disclosed Funding Rounds $325,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 04 ,2024 | Series C | $325,000,000 | |
| September, 05 ,2024 | Series C | Undisclosed Amount |
Hitachi Ventures
nVentures
Rock Springs Capital
Luma Group
Westlake Village BioPartners®
Byers Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
